PAGE-B Score (HCC Risk in Chronic Hepatitis B on Antivirals)

Estimates the 5-year risk of hepatocellular carcinoma in adults with chronic hepatitis B on long-term nucleos(t)ide analogue therapy (entecavir or tenofovir) from age, sex, and platelet count, to guide HCC surveillance intensity.